176 related articles for article (PubMed ID: 8864317)
21. Methotrexate pharmacokinetic is influenced by co-administration of cyclosporin in rheumatoid arthritis patients. Results from a randomized clinical trial.
Odderskov C; Stengaard-Pedersen K; Ellingsen T; Hornung N
Scand J Clin Lab Invest; 2020 May; 80(3):185-190. PubMed ID: 31876200
[TBL] [Abstract][Full Text] [Related]
22. Influence of sulphasalazine, methotrexate, and the combination of both on plasma homocysteine concentrations in patients with rheumatoid arthritis.
Haagsma CJ; Blom HJ; van Riel PL; van't Hof MA; Giesendorf BA; van Oppenraaij-Emmerzaal D; van de Putte LB
Ann Rheum Dis; 1999 Feb; 58(2):79-84. PubMed ID: 10343521
[TBL] [Abstract][Full Text] [Related]
23. Longterm combination therapy of refractory and destructive rheumatoid arthritis with methotrexate (MTX) and intramuscular gold or other disease modifying antirheumatic drugs compared to MTX monotherapy.
Rau R; Schleusser B; Herborn G; Karger T
J Rheumatol; 1998 Aug; 25(8):1485-92. PubMed ID: 9712088
[TBL] [Abstract][Full Text] [Related]
24. A population pharmacokinetic model for low-dose methotrexate and its polyglutamated metabolites in red blood cells.
Korell J; Stamp LK; Barclay ML; Dalrymple JM; Drake J; Zhang M; Duffull SB
Clin Pharmacokinet; 2013 Jun; 52(6):475-85. PubMed ID: 23483363
[TBL] [Abstract][Full Text] [Related]
25. The influence of methotrexate on the gene expression of the pro-inflammatory cytokine IL-12A in the therapy of rheumatoid arthritis.
Hobl EL; Mader RM; Erlacher L; Duhm B; Mustak M; Bröll H; Högger P; Kalipciyan M; Jilma B
Clin Exp Rheumatol; 2011; 29(6):963-9. PubMed ID: 22133036
[TBL] [Abstract][Full Text] [Related]
26. Clinical pharmacokinetics of low-dose pulse methotrexate in rheumatoid arthritis.
Bannwarth B; Péhourcq F; Schaeverbeke T; Dehais J
Clin Pharmacokinet; 1996 Mar; 30(3):194-210. PubMed ID: 8882301
[TBL] [Abstract][Full Text] [Related]
27. Randomised comparison of combined step-down prednisolone, methotrexate and sulphasalazine with sulphasalazine alone in early rheumatoid arthritis.
Boers M; Verhoeven AC; Markusse HM; van de Laar MA; Westhovens R; van Denderen JC; van Zeben D; Dijkmans BA; Peeters AJ; Jacobs P; van den Brink HR; Schouten HJ; van der Heijde DM; Boonen A; van der Linden S
Lancet; 1997 Aug; 350(9074):309-18. PubMed ID: 9251634
[TBL] [Abstract][Full Text] [Related]
28. Is there an interaction between low doses of corticosteroids and methotrexate in patients with rheumatoid arthritis? A pharmacokinetic study in 33 patients.
Lafforgue P; Monjanel-Mouterde S; Durand A; Catalin J; Acquaviva PC
J Rheumatol; 1993 Feb; 20(2):263-7. PubMed ID: 8474062
[TBL] [Abstract][Full Text] [Related]
29. Fostamatinib, a Syk-kinase inhibitor, does not affect methotrexate pharmacokinetics in patients with rheumatoid arthritis.
Baluom M; Samara E; Grossbard EB; Lau DT
J Clin Pharmacol; 2011 Sep; 51(9):1310-8. PubMed ID: 21209239
[TBL] [Abstract][Full Text] [Related]
30. Total and free methotrexate pharmacokinetics, with and without piroxicam, in rheumatoid arthritis patients.
Combe B; Edno L; Lafforgue P; Bologna C; Bernard JC; Acquaviva P; Sany J; Bressolle F
Br J Rheumatol; 1995 May; 34(5):421-8. PubMed ID: 7788170
[TBL] [Abstract][Full Text] [Related]
31. Golimumab pharmacokinetics after repeated subcutaneous and intravenous administrations in patients with rheumatoid arthritis and the effect of concomitant methotrexate: an open-label, randomized study.
Zhuang Y; Xu Z; Frederick B; de Vries DE; Ford JA; Keen M; Doyle MK; Petty KJ; Davis HM; Zhou H
Clin Ther; 2012 Jan; 34(1):77-90. PubMed ID: 22169051
[TBL] [Abstract][Full Text] [Related]
32. Efficacy of triple DMARD therapy in patients with RA with suboptimal response to methotrexate.
O'Dell JR; Haire C; Erikson N; Drymalski W; Palmer W; Maloley P; Klassen LW; Wees S; Moore GF
J Rheumatol Suppl; 1996 Mar; 44():72-4. PubMed ID: 8833058
[TBL] [Abstract][Full Text] [Related]
33. Effect of methotrexate alone or in combination with sulphasalazine on the production and circulating concentrations of cytokines and their antagonists. Longitudinal evaluation in patients with rheumatoid arthritis.
Barrera P; Haagsma CJ; Boerbooms AM; Van Riel PL; Borm GF; Van de Putte LB; Van der Meer JW
Br J Rheumatol; 1995 Aug; 34(8):747-55. PubMed ID: 7551660
[TBL] [Abstract][Full Text] [Related]
34. Methotrexate Dose in Patients With Early Rheumatoid Arthritis Impacts Methotrexate Polyglutamate Pharmacokinetics, Adalimumab Pharmacokinetics, and Efficacy: Pharmacokinetic and Exposure-response Analysis of the CONCERTO Trial.
Goss SL; Klein CE; Jin Z; Locke CS; Rodila RC; Kupper H; Burmester GR; Awni WM
Clin Ther; 2018 Feb; 40(2):309-319. PubMed ID: 29402521
[TBL] [Abstract][Full Text] [Related]
35. When to adjust therapy in patients with rheumatoid arthritis after initiation of etanercept plus methotrexate or methotrexate alone: findings from a randomized study (COMET).
Dougados MR; van der Heijde DM; Brault Y; Koenig AS; Logeart IS
J Rheumatol; 2014 Oct; 41(10):1922-34. PubMed ID: 25128520
[TBL] [Abstract][Full Text] [Related]
36. Methotrexate therapy in rheumatoid arthritis after failure to sulphasalazine: to switch or to add?
Schipper LG; Fransen J; Barrera P; den Broeder AA; Van Riel PL
Rheumatology (Oxford); 2009 Oct; 48(10):1247-53. PubMed ID: 19638454
[TBL] [Abstract][Full Text] [Related]
37. Determinants of red blood cell methotrexate polyglutamate concentrations in rheumatoid arthritis patients receiving long-term methotrexate treatment.
Stamp LK; O'Donnell JL; Chapman PT; Zhang M; Frampton C; James J; Barclay ML
Arthritis Rheum; 2009 Aug; 60(8):2248-56. PubMed ID: 19644853
[TBL] [Abstract][Full Text] [Related]
38. Triple Oral Therapy Versus Antitumor Necrosis Factor Plus Methotrexate (MTX) in Patients with Rheumatoid Arthritis and Inadequate Response to MTX: A Systematic Literature Review.
Mary J; De Bandt M; Lukas C; Morel J; Combe B
J Rheumatol; 2017 Jun; 44(6):773-779. PubMed ID: 28412710
[TBL] [Abstract][Full Text] [Related]
39. A proof-of-concept and drug-drug interaction study of pamapimod, a novel p38 MAP kinase inhibitor, with methotrexate in patients with rheumatoid arthritis.
Zhang X; Huang Y; Navarro MT; Hisoire G; Caulfield JP
J Clin Pharmacol; 2010 Sep; 50(9):1031-8. PubMed ID: 20100913
[TBL] [Abstract][Full Text] [Related]
40. A Multi-Biomarker Disease Activity Score and the Choice of Second-Line Therapy in Early Rheumatoid Arthritis After Methotrexate Failure.
Hambardzumyan K; Saevarsdottir S; Forslind K; Petersson IF; Wallman JK; Ernestam S; Bolce RJ; van Vollenhoven RF
Arthritis Rheumatol; 2017 May; 69(5):953-963. PubMed ID: 27992691
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
